A Six-Week Safety Study of an Investigational Ophthalmic Solution

NCT01698814 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: AL-4943A Ophthalmic Solution
DRUG: AL-4943A Ophthalmic Solution Vehicle

Sponsor

Alcon Research